David Buttross, MD
Psychiatry · Lake Charles, LANPI 1083615421
Payments from drug & device makers
Across 287 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sunovion Pharmaceuticals Inc.$651
- Otsuka America Pharmaceutical, Inc.$598
- Alkermes, Inc.$421
- Johnson & Johnson$299
- Neurocrine Biosciences, Inc.$282
- plus $584 from 14 others
What the payments were for
- Food & beverage$4,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 97 | $1,366 |
| Sunovion Pharmaceuticals Inc. | 47 | $651 |
| Otsuka America Pharmaceutical, Inc. | 48 | $598 |
| Alkermes, Inc. | 27 | $421 |
| Johnson & Johnson | 17 | $299 |
| Neurocrine Biosciences, Inc. | 14 | $282 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $117 |
| Indivior Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $74 |
| Merck | 4 | $65 |
| Acadia Pharmaceuticals Inc | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Eisai Inc. | 3 | $40 |
| Tris Pharma Inc | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Corium, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
| Neuronetics, Inc. | 1 | $10 |
| OWP Pharmaceuticals, Inc. | 1 | $5 |
How this compares
$4,201 in reported general payments places this provider in the 85th percentile of 474 psychiatry providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Benztropine Mesylate | 15 | $137 |
| Trazodone Hcl | 11 | $108 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lake Charles
- Kashinath YadalamLake Charles$3.8M
- Patrick HayesLake Charles$853K
- David MurdockLake Charles$18K
- Jayendra PatelLake Charles$13K
- Guy BrannonShreveport$1.4M
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.